GLP-1 Ra seems to have a rather favourable effect in SARS-CoV-2 infected patients [14,45,51,54] and may represent an appropriate treatment for non-critically ill patients with T2DM [40,52]. Here, GLP1R is linked to type 2 diabetes mellitus.